Currently, there are 258.45M common shares owned by the public and among those 244.48M shares have been available to trade.
The company’s stock has a 5-day price change of 8.68% and 26.33% over the past three months. SW shares are trading 20.26% year to date (YTD), with the 12-month market performance up to 28.08% higher. It has a 12-month low price of $30.62 and touched a high of $50.13 over the same period. SW has an average intraday trading volume of 4.14 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.40%, 12.74%, and 28.28% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Smurfit WestRock plc (NYSE: SW) shares accounts for 18.48% of the company’s 258.45M shares outstanding.
It has a market capitalization of $12.72B and a beta (3y monthly) value of 1.06. The stock’s trailing 12-month PE ratio is 15.57, while the earnings-per-share (ttm) stands at $3.15. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.44% over the week and 1.30% over the month.
Earnings per share for the fiscal year are expected to decrease by -19.70%, and 42.24% over the next financial year.
Looking at the support for the SW, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Sector Perform rating for the stock in a research note on July 12, 2024, with the firm’s price target at $52. JP Morgan coverage for the Smurfit WestRock plc (SW) stock in a research note released on July 12, 2024 offered a Overweight rating with a price target of $66. Stifel was of a view on July 09, 2024 that the stock is Buy, while Exane BNP Paribas gave the stock Outperform rating on July 09, 2024, issuing a price target of $55.
